Do pharmaceutical prices respond to potential patient out-of-pocket expenses?

RAND Journal of Economics

Volumn 33, Issue 3, 2002, Pages 469-487

  Pavcnik, Nina ^a  

^a NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036762637     PISSN: 07416261     EISSN: None     Source Type: Journal    
DOI: 10.2307/3087468     Document Type: Conference Paper

References (11)

1. The Association of the British Pharmaceutical Industry (ABPI). "Summary of Pricing and Reimbursement Measures Taken by European Countries Since January 1993." Mimeo, ABPI, 1996.
2. Ellison, S.F., Cockburn, I., Griliches Z., and Hausman, J. "Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins." RAND Journal of Economics, Vol. 28 (1997), pp. 426-446.
3. Hellerstein, J.K. "The Importance of the Physician in the Generic Versus Trade-Name Prescription Decision." RAND Journal of Economics, Vol. 29 (1998), pp. 108-136.
4. Newhouse, J.P. and The Insurance Experiment Group. Free for All? Lessons from the RAND Health Insurance Experiment. Cambridge, Mass.: Harvard University Press, 1993.
5. Reynolds, J.E.F., ed. Martindale: The Extra Pharmacopoeia, 31st ed. London: Pharmaceutical Press, 1996.
6. Schweitzer, S.O. Pharmaceutical Economics and Policy. New York: Oxford University Press, 1997.
7. Scott Morton, F. "The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules." RAND Journal of Economics, Vol. 28 (1997), pp. 269-290.
8. Sitzius-Zehender, H. "Federal Republic of Germany." In R.N. Spivey, A.I. Wertheimer, and T.D. Rucker, eds., International Pharmaceutical Services: The Drug Industry and Pharmacy Practice in Twenty-Three Major Countries of the World. New York: Pharmaceutical Products Press, 1992.
9. Stern, S. "Product Demand in Pharmaceutical Markets." Department of Economics, University of Illinois Urbana-Champaign, 1995.
10. Sullivan, K. "Recent Legislative Changes in Germany." In Pricing and Reimbursement of Pharmaceuticals, European Pharma Law Centre Pharma Law Report No. 7, 1993.
11. Zweifel, P. and Crivelli, L. "Price Regulation of Drugs: Lessons from Germany." Journal of Regulatory Economics, Vol. 10 (1996), pp. 257-273.